Work

Nonclinical Toxicology and Biocompatibility Program Supporting Clinical Development and Registration of the Port Delivery System With Ranibizumab for Neovascular Age-Related Macular Degeneration

Year: 2020
Type: article
Institution: Genentech
Language: English
Subfield: Ophthalmology
Field: Medicine
Open Access status: closed
Funder: Genentech
OpenAlex ID: W3099337736
FWCI: 1.588
Cites: 22
Cited by: 14
Related to: 10